Protocol Ledger

NCT07362810 · Phase II · RECRUITING

G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation

Interventional Phase II clinical trial protocol NCT07362810 sponsored by Fudan University in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-01-22 Enrollment: 224 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07362810
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)224 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07362810
Protocol FieldVerified Registry Value
NCT IdentifierNCT07362810
Consolidated Lead SponsorFudan University
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment224 participants (ESTIMATED)
Registered Start Date2026-01-22
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07362810
Hospital Research SiteLocationSite Profile
The First Affiliated Hospital Of Fujian Medical UniversityFuzhou, ChinaOpen Hospital Dossier ->
The first affiliated hospital of Zhengzhou UniversityZhengzhou, ChinaOpen Hospital Dossier ->
Jiangxi Cancer HospitalNanchang, ChinaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI